Exam 10: Molecular Biology of the Gene

Diabetes mellitus is a metabolic disease that is characterized by the buildup of glucose in the blood, or hyperglycemia. Diabetes results either from the pancreas not being able to produce the hormone insulin (type 1 diabetes) or if the body's cells become resistant to insulin (type 2 diabetes). Insulin is a protein that binds to receptors on cell surfaces to allow glucose to enter the cell. In order to manage the disease, type 1 diabetics require frequent insulin injections. Until the 1970s, insulin was obtained from processing the pancreases of large mammals such as cows and pigs; it was then purified for medicinal use. This all changed in the 1970s with the advent of recombinant DNA technology, which allows scientists to insert genes from other species into bacterial plasmids and have bacteria produce proteins from these other species' genes. In 1978, the gene that codes for human insulin was added to a bacterial plasmid and bacteria were used to produce human insulin. These bacteria acted as mini-factories that produced human insulin for type 1 diabetes patients. Today, the production of human insulin from bacteria is commonplace and is a multibillion dollar market for pharmaceutical companies. -In order for bacterial cells to be able to produce the human insulin protein, which of the following is not required?

The directions for each amino acid in a polypeptide are indicated by a codon that consists of ________ nucleotides in an RNA molecule.

Which of the following statements regarding a DNA double helix is true?

Which of the following statements regarding the structure of DNA is false?

Exposure to the HIV virus doesn't necessarily mean that a person will develop AIDS. Some people have genetic resistance to infection by HIV. Dr. Stephen O'Brien from the U.S. National Cancer Institute has recently identified a mutant form of a gene, called CCR5, that can protect against HIV infection. The mutation probably originated in Europe and became more prevalent among survivors of the bubonic plague. The mutated gene prevents the plague bacteria from attaching to cell membranes and, therefore, from entering and infecting body cells. Although the HIV virus is very different from the bacteria that causes the plague, both diseases affect the exact same cells and use the same method of infection. The presence of the mutated gene in descendants of plague survivors helps prevent them from contracting AIDS. Pharmaceutical companies are using this information as the basis for a new approach to AIDS prevention. This could be very important in areas of the world where the mutation is scarce or absent, such as Africa. -Imagine that a pharmaceutical company was successful at producing a drug based on the CCR5 gene product that is effective at preventing the contraction of AIDS. However, shortly after the drug has been in use, patients and doctors report that the drug is not as effective as it once was. What is the most likely explanation for this result?